Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Andrew Moshfeghi, MD, MBA

    TitleAssociate Professor of Clinical Ophthalmology
    SchoolKeck School of Medicine of USC
    DepartmentOphthalmology
    AddressHC4 4900 1450 San Pablo Street
    Off Campus
    Los Angeles California 90033-9224
    Emailmoshfega@usc.edu
    vCardDownload vCard
      Other Positions
      TitleDirector of Clinical Trials


      Collapse Overview 
      Collapse Overview
      Andrew A. Moshfeghi, M.D., M.B.A. serves as Associate Professor and Director of the Clinical Trials Unit for the Department of Ophthalmology at the USC Eye Institute. Dr. Moshfeghi is a noted vitreoretinal surgeon and specialist in diseases of the vitreous, retina, and macula. His research focuses on evaluation of intraocular pharmacotherapeutics, application of novel ophthalmic imaging techniques, and evaluation of health care utilization trends in ophthalmology. He sees patients at the USC Eye Institute in Los Angeles and Pasadena.


      Collapse Biography 
      Collapse Awards and Honors
      Ronald G Michels Fellowship Foundation2005  - 2006Ronald G. Michels Fellowship Foundation Award
      American Society of Retina Specialists2015  - 2015ASRS Honor Award
      American Academy of Ophthalmology2013  - 2013AAO Achievement Award
      Castle Connolly Top Doctors2012  - 2015Top Doctors Award
      The Best Doctors in America2009  - 2015Best Doctors Award

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse Faculty Mentoring

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Wood EH, Moshfeghi A, Nudleman ED, Moshfeghi DM. Evaluation of Visunex Medical's PanoCam(TM) LT and PanoCam(TM) Pro wide-field imaging systems for the screening of ROP in newborn infants. Expert Rev Med Devices. 2016 Aug; 13(8):705-12. PMID: 27424884.
        View in: PubMed
      2. Kashani AH, Zhang Y, Capone A, Drenser KA, Puliafito C, Moshfeghi A, Williams GA, Trese MT. Impaired Retinal Perfusion Resulting From Vitreoretinal Traction: A Mechanism of Retinal Vascular Insufficiency. Ophthalmic Surg Lasers Imaging Retina. 2016 Mar 1; 47(3):1-11. PMID: 26985791.
        View in: PubMed
      3. Vaziri K, Schwartz SG, Flynn HW, Kishor KS, Moshfeghi A. Eye-related Emergency Department Visits in the United States, 2010. Ophthalmology. 2016 Apr; 123(4):917-9. PMID: 26704884.
        View in: PubMed
      4. Kashani AH, Lee SY, Moshfeghi A, Durbin MK, Puliafito CA. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VENOUS OCCLUSION. Retina. 2015 Nov; 35(11):2323-31. PMID: 26457395.
        View in: PubMed
      5. Brilliant MH, Vaziri K, Connor TB, Schwartz SG, Carroll JJ, McCarty CA, Schrodi SJ, Hebbring SJ, Kishor KS, Flynn HW, Moshfeghi A, Moshfeghi DM, Fini ME, McKay BS. Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration. Am J Med. 2016 Mar; 129(3):292-8. PMID: 26524704.
        View in: PubMed
      6. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi A, Smiddy WE, Flynn HW. Rates of Reoperation and Retinal Detachment after Macular Hole Surgery. Ophthalmology. 2016 Jan; 123(1):26-31. PMID: 26505804.
        View in: PubMed
      7. Kim EL, Tran JS, Moshfeghi A. Self-Reported Characteristics of Retina Specialists in the United States. Ophthalmology. 2016 Feb; 123(2):438-40. PMID: 26411837.
        View in: PubMed
      8. Pershing S, Vaziri K, Albini TA, Moshfeghi DM, Moshfeghi A. Reply. Am J Ophthalmol. 2015 Aug; 160(2):392. PMID: 26187878.
        View in: PubMed
      9. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi A, Luo H, Kang Z, Sadda S, Feuer W, Rosenfeld PJ. Association Between Growth of Geographic Atrophy and the Complement Factor I Locus. Ophthalmic Surg Lasers Imaging Retina. 2015 Jul 1; 46(7):772-4. PMID: 26247461.
        View in: PubMed
      10. Gregori NZ, Flynn HW, Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi A, Fortun JA, Kovach JL, Dubovy SR, Albini TA, Davis JL, Berrocal AM, Smiddy WE. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun 1; 46(6):643-8. PMID: 26114845.
        View in: PubMed
      11. Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, Witkin DI, Leung J, Albini TA, Moshfeghi A, Batlle IR, Sobrin L, Eliott D. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin. Ophthalmology. 2015 Jul; 122(7):1438-51. PMID: 25886796.
        View in: PubMed
      12. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi DM, Moshfeghi A, Flynn HW. Incidence of postoperative suprachoroidal hemorrhage after glaucoma filtration surgeries in the United States. Clin Ophthalmol. 2015; 9:579-84. PMID: 25897196.
        View in: PubMed
      13. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi A, Sadda S, Feuer W, Rosenfeld PJ. Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study. Ophthalmic Surg Lasers Imaging Retina. 2015 Apr 1; 46(4):413-22. PMID: 25970861.
        View in: PubMed
      14. Vaziri K, Moshfeghi DM, Hernandez-Boussard T, Callaway NF, Moshfeghi A. Ambulatory surgery center utilization by vitreoretinal surgeons: 1999-2011. Ophthalmic Surg Lasers Imaging Retina. 2015 Mar 1; 46(3):355-61. PMID: 25856823.
        View in: PubMed
      15. Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi A, Flynn HW. Incidence of bleb-associated endophthalmitis in the United States. Clin Ophthalmol. 2015; 9:317-22. PMID: 25709395.
        View in: PubMed
      16. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi A. Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the united states. Am J Ophthalmol. 2015 Mar; 159(3):498-504. PMID: 25486541.
        View in: PubMed
      17. Nicholson LB, Kim BT, Jardón J, Townsend-Pico W, Santos C, Moshfeghi A, Albini TA, Eliott D, Sobrin L. Severe bilateral ischemic retinal vasculitis following cataract surgery. Ophthalmic Surg Lasers Imaging Retina. 2014 Jul 1; 45(4):338-42. PMID: 25127533.
        View in: PubMed
      18. Garcia Filho CA, Yehoshua Z, Gregori G, Nunes RP, Penha FM, Moshfeghi A, Zhang K, Feuer W, Rosenfeld PJ. Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan-Feb; 45(1):18-31. PMID: 24354307.
        View in: PubMed
      19. Cabrera M, Gonzalez A, Albini TA, Rowaan C, Aguilar M, Lee W, Fortun JA, Moshfeghi A, Flynn HW, Parel JM. Differential flow rate of commercially available triamcinolone with and without preservative through small-gauge needles. Ophthalmic Surg Lasers Imaging Retina. 2014 Jan 1; 45(1):54-7. PMID: 24392913.
        View in: PubMed
      20. Yehoshua Z, Alexandre de Amorim Garcia Filho C, Nunes RP, Gregori G, Penha FM, Moshfeghi A, Zhang K, Sadda S, Feuer W, Rosenfeld PJ. Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration: The COMPLETE Study. Ophthalmology. 2014 Mar; 121(3):693-701. PMID: 24289920.
        View in: PubMed
      21. Duker JS, Moshfeghi A. Ocriplasmin: a medical or surgical therapy? Retina. 2013 Nov-Dec; 33(10):2001-2. PMID: 24113274.
        View in: PubMed
      22. Vaziri K, Moshfeghi DM, Moshfeghi A. Feasibility of telemedicine in detecting diabetic retinopathy and age-related macular degeneration. Semin Ophthalmol. 2015 Mar; 30(2):81-95. PMID: 24171781.
        View in: PubMed
      23. Vaziri K, Moshfeghi A, Moshfeghi DM. Fundus findings in chronic granulomatous disease. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):390-2. PMID: 23799791.
        View in: PubMed
      24. Nunes RP, Gregori G, Yehoshua Z, Stetson PF, Feuer W, Moshfeghi A, Rosenfeld PJ. Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):344-59. PMID: 23883530.
        View in: PubMed
      25. Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, Moshfeghi A, Fortun JA. Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesion. Ophthalmic Surg Lasers Imaging Retina. 2013 Jul-Aug; 44(4):334-43. PMID: 23883268.
        View in: PubMed
      26. Fijalkowski N, Zheng LL, Henderson MT, Moshfeghi A, Maltenfort M, Moshfeghi DM. Academic productivity and its relationship to physician salaries in the University of California Healthcare System. South Med J. 2013 Jul; 106(7):415-21. PMID: 23820322.
        View in: PubMed
      27. Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Moshfeghi A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. 16 and 24 Gy low-voltage X-ray irradiation with ranibizumab therapy for neovascular age-related macular degeneration: 12-month outcomes. Am J Ophthalmol. 2013 Jun; 155(6):1000-1008.e2. PMID: 23497847.
        View in: PubMed
      28. Moshfeghi A. 8 questions with Dr. Puliafito. Interview by Carmen A Puliafito. Ophthalmic Surg Lasers Imaging Retina. 2013 Jan-Feb; 44(1):103-4. PMID: 23410818.
        View in: PubMed
      29. Yeh S, Albini TA, Moshfeghi A, Nussenblatt RB. Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and intravitreal biologics for ocular inflammation. Am J Ophthalmol. 2012 Sep; 154(3):429-435.e2. PMID: 22898344.
        View in: PubMed
      30. Moshfeghi A, Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. 16 Gy low-voltage x-ray irradiation followed by as needed ranibizumab therapy for age-related macular degeneration: 12 month outcomes of a 'radiation-first' strategy. Br J Ophthalmol. 2012 Oct; 96(10):1320-4. PMID: 22895887.
        View in: PubMed
      31. Leng T, Jaben KA, Zheng L, Yang J, Paulus YM, Moshfeghi A, Maltenfort MG, Campbell PG, Ratliff JK, Moshfeghi DM. The influence of medical school and residency training program upon choice of an academic career and academic productivity among otolaryngology faculty in the United States of America: our experience of 1433 academic otolaryngologists. Clin Otolaryngol. 2012 Feb; 37(1):58-62. PMID: 22433138.
        View in: PubMed
      32. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. 24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging. 2012 Jan-Feb; 43(1):20-4. PMID: 22251841.
        View in: PubMed
      33. Thayil SM, Albini TA, Nazari H, Moshfeghi A, Parel JM, Rao NA, Karakousis PC. Local Ischemia and Increased Expression of Vascular Endothelial Growth Factor Following Ocular Dissemination of Mycobacterium tuberculosis. PLoS One. 2011; 6(12):e28383. PMID: 22162767.
        View in: PubMed
      34. Moshfeghi A, Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. 16-Gy low-voltage x-ray irradiation followed by as-needed ranibizumab therapy for AMD: 6-month outcomes of a "radiation-first" strategy. Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec; 42(6):460-7. PMID: 21830745.
        View in: PubMed
      35. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi A, Shusterman EM, Kaiser PK, Sanislo SR, Gertner M, Moshfeghi DM. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes. Ophthalmic Surg Lasers Imaging. 2011 Nov-Dec; 42(6):468-73. PMID: 21830747.
        View in: PubMed
      36. Silva RA, Moshfeghi A, Kaiser PK, Singh RP, Moshfeghi DM. Radiation treatment for age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):121-30. PMID: 21609224.
        View in: PubMed
      37. Moshfeghi A. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin Ophthalmol. 2011 May; 26(3):139-48. PMID: 21609227.
        View in: PubMed
      38. Campbell PG, Awe OO, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi A, Ratliff JK. Medical school and residency influence on choice of an academic career and academic productivity among neurosurgery faculty in the United States. Clinical article. J Neurosurg. 2011 Aug; 115(2):380-6. PMID: 21495810.
        View in: PubMed
      39. Campbell PG, Lee YH, Bell RD, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi A, Ratliff JK. Medical school and residency influence on choice of an academic career and academic productivity among US neurology faculty. Arch Neurol. 2011 Aug; 68(8):999-1004. PMID: 21482917.
        View in: PubMed
      40. Moshfeghi A, Rosenfeld PJ, Flynn HW, Schwartz SG, Davis JL, Murray TG, Smiddy WE, Berrocal AM, Dubovy SR, Lee WH, Albini TA, Lalwani GA, Kovach JL, Puliafito CA. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center. Retina. 2011 Apr; 31(4):662-8. PMID: 21836400.
        View in: PubMed
      41. Moshfeghi A, Albini TA, Kitchens JW, Leng T, Moshfeghi DM. The vitreous trap: a simple, surgeon-controlled technique for obtaining undiluted vitreous and subretinal specimens during pars plana vitrectomy. Retina. 2011 Feb; 31(2):426-7; author reply 427. PMID: 21233788.
        View in: PubMed
      42. Moshfeghi A, Charalel RA, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Declining incidence of neonatal endophthalmitis in the United States. Am J Ophthalmol. 2011 Jan; 151(1):59-65.e1. PMID: 20970776.
        View in: PubMed
      43. Javey G, Moshfeghi AN, Moshfeghi A. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010; 41 Online:e1-5. PMID: 21155520.
        View in: PubMed
      44. Tang J, Rivers MB, Moshfeghi A, Flynn HW, Chan CC. Pathology of macular foveoschisis associated with degenerative myopia. J Ophthalmol. 2010; 2010. PMID: 20814547.
        View in: PubMed
      45. Javey G, Moshfeghi AN, Moshfeghi A. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug; 41(4):1-5. PMID: 21728252.
        View in: PubMed
      46. Cavalcante LL, Cavalcante ML, Murray TG, Vigoda MM, Piña Y, Decatur CL, Davis RP, Olmos LC, Schefler AC, Parrott MB, Alliman KJ, Flynn HW, Moshfeghi A. Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol. 2010; 4:519-24. PMID: 20535228.
        View in: PubMed
      47. Shirodkar AR, Flynn HW, Alliman K, Lalwani GA, Alabiad C, Moshfeghi A, Miller D. The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clin Ophthalmol. 2010; 4:211-4. PMID: 20463786.
        View in: PubMed
      48. Javey G, Schwartz SG, Moshfeghi A, Asrani S, Flynn HW. Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime. Clin Ophthalmol. 2010; 4:101-4. PMID: 20234775.
        View in: PubMed
      49. Javey G, Albini TA, Moshfeghi A, Kelly KT, Flynn HW. Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina. 2010 Jan; 30(1):184-5. PMID: 19996824.
        View in: PubMed
      50. Moshfeghi A, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina. 2009 May; 29(5):689-98. PMID: 19373129.
        View in: PubMed
      51. Jockovich ME, Murray TG, Clifford PD, Moshfeghi A. Posterior juxtascleral injection of anecortave acetate: magnetic resonance and echographic imaging and localization in rabbit eyes. Retina. 2007 Feb; 27(2):247-52. PMID: 17290209.
        View in: PubMed
      52. Moshfeghi A, Harrison SA, Reinstein DZ, Ferrone PJ. Valsalva-like retinopathy following hyperopic laser in situ keratomileusis. Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec; 37(6):486-8. PMID: 17152544.
        View in: PubMed
      53. Moshfeghi A, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology. 2006 Nov; 113(11):2002.e1-12. PMID: 17027972.
        View in: PubMed
      54. Scott IU, Moshfeghi A, Flynn HW. Surgical management of macular retinoschisis associated with high myopia. Arch Ophthalmol. 2006 Aug; 124(8):1197-9. PMID: 16908827.
        View in: PubMed
      55. Moshfeghi A, Peyman GA. Micro- and nanoparticulates. Adv Drug Deliv Rev. 2005 Dec 13; 57(14):2047-52. PMID: 16298454.
        View in: PubMed
      56. Rosenfeld PJ, Moshfeghi A, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging. 2005 Jul-Aug; 36(4):331-5. PMID: 16156152.
        View in: PubMed
      57. Moshfeghi A, Puliafito CA. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert Opin Investig Drugs. 2005 May; 14(5):671-82. PMID: 15926872.
        View in: PubMed
      58. Soheilian M, Feghi M, Yazdani S, Anisian A, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Moshfeghi A, Peyman GA. Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic Surg Lasers Imaging. 2005 May-Jun; 36(3):189-96. PMID: 15957475.
        View in: PubMed
      59. Moshfeghi A, Harrison SA, Ferrone PJ. Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic Surg Lasers Imaging. 2005 Mar-Apr; 36(2):163-6. PMID: 15792321.
        View in: PubMed
      60. Kitchens JW, Flynn HW, Moshfeghi A, Puliafito CA. Idiopathic macular hole with extensive subretinal fluid: clinical and optical coherence tomography features before and after surgery. Am J Ophthalmol. 2005 Feb; 139(2):383-6. PMID: 15734018.
        View in: PubMed
      61. Moshfeghi A, Flynn HW, Elner SG, Puliafito CA, Gass JD. Persistent outer retinal defect after successful macular hole repair. Am J Ophthalmol. 2005 Jan; 139(1):183-4. PMID: 15652846.
        View in: PubMed
      62. Moshfeghi A, Banach MJ, Salam GA, Ferrone PJ. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Arch Ophthalmol. 2004 Dec; 122(12):1816-8. PMID: 15596585.
        View in: PubMed
      63. Soheilian M, Abolhasani A, Ahmadieh H, Azarmina M, Dehgan MH, Mashavekhi A, Siadat F, Moshfeghi A, Peyman GA. Management of magnetic intravitreal foreign bodies in 71 eyes. Ophthalmic Surg Lasers Imaging. 2004 Sep-Oct; 35(5):372-8. PMID: 15497547.
        View in: PubMed
      64. Moshfeghi A, Scott IU, Flynn HW, Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol. 2004 Sep; 138(3):489-92. PMID: 15364241.
        View in: PubMed
      65. Moshfeghi A, Awner S, Salam GA, Ferrone PJ. Excellent visual outcome and reversal of dragging after lens sparing vitrectomy for progressive tractional stage 4a retinopathy of prematurity retinal detachment. Retina. 2004 Aug; 24(4):615-6. PMID: 15300086.
        View in: PubMed
      66. Moshfeghi A, Pendergast SD, Hartzer MK, Ferrone PJ. The effects of scleral buckling on young rabbit eyes. Arch Ophthalmol. 2004 Apr; 122(4):473-6. PMID: 15078663.
        View in: PubMed
      67. Moshfeghi A, Salam GA, Deramo VA, Shakin EP, Ferrone PJ, Shakin JL, Fastenberg DM. Management of macular holes that develop after retinal detachment repair. Am J Ophthalmol. 2003 Nov; 136(5):895-9. PMID: 14597042.
        View in: PubMed
      68. Peyman GA, Genaidy M, Yoneya S, Men G, Ghahramani F, Kuo PC, Bezerra Y, Nishiyama-Ito Y, Moshfeghi A. Transpupillary thermotherapy threshold parameters: effect of indocyanine green pretreatment. Retina. 2003 Jun; 23(3):378-86. PMID: 12824840.
        View in: PubMed
      69. El-Dessouky ES, Moshfeghi A, Peyman GA, Yoneya S, Mori K, Kazi AA, Moshfeghi DM. Toxicity of the photosensitizer NPe6 following intravitreal injection. Ophthalmic Surg Lasers. 2001 Jul-Aug; 32(4):316-21. PMID: 11475398.
        View in: PubMed
      70. Moshfeghi DM, Moshfeghi A, Belafsky PC, Kim G, Sheffler M, Fink AJ, Kastl PR. Mardi Gras eye injury survey, 1998-1999. South Med J. 2000 Nov; 93(11):1083-6. PMID: 11095558.
        View in: PubMed
      71. Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi A. Threshold power levels for NPe6 photodynamic therapy. Ophthalmic Surg Lasers. 2000 Mar-Apr; 31(2):136-42. PMID: 10743925.
        View in: PubMed
      72. Moshfeghi DM, Peyman GA, Moshfeghi A, Khoobehi B, Primbs GB, Crean DH. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies. Ophthalmic Surg Lasers. 1998 Aug; 29(8):663-8. PMID: 9715492.
        View in: PubMed
      73. Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B. Fluorescent vesicle angiography with sodium fluorescein and indocyanine green. Ophthalmic Surg Lasers. 1996 Apr; 27(4):279-84. PMID: 8705742.
        View in: PubMed